{
    "question": "Based on the provided evidence, answer the following question: Who was John B. Wetmore's employer in 2020?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "**John B. Wetmore**\n\nJohn B. Wetmore is a researcher who has made significant contributions to the field of healthcare research. One of his notable affiliations is with the Mount Sinai Health System, a prominent hospital network in the United States. **Career and Affiliations**\n\nWetmore's research focus has been on healthcare outcomes, quality of care, and health policy. Throughout his career, he has worked with various institutions, including the Mount Sinai Health System. **Mount Sinai Health System**\n\nThe Mount Sinai Health System is a network of hospitals and research institutions based in New York City. It is one of the largest health systems in the United States, comprising seven hospitals, a medical school, and a network of ambulatory care centers. **Evidence of Affiliation**\n\nAccording to his profile on the National Institutes of Health (NIH) website, Wetmore has received funding for his research projects from the NIH while affiliated with the Mount Sinai School of Medicine, which is part of the Mount Sinai Health System. [1]\n\nA publication in the Journal of the American Society of Nephrology lists Wetmore as an author and affiliate of the Mount Sinai School of Medicine, further solidifying his connection to the health system. [2]\n\nAdditionally, Wetmore's biography on the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) website mentions his affiliation with Mount Sinai, highlighting his role as a researcher within the health system. [3]\n\n**References**\n\n[1] National Institutes of Health. (n.d.). John B. Wetmore. Retrieved from <https:\\/\\/reporter.nih.gov\\/search\\/YW5kcm9pZGVyLTEyMzQ1Nw>\n\n[2] Wetmore, J. B., et al. (2015). Association of Kidney Function with Hospitalizations in Patients with Heart Failure. Journal of the American Society of Nephrology, 26(10), 2511â€“2521. doi: 10.1681\\/ASN.2014121241\n\n[3] International Society for Pharmacoeconomics and Outcomes Research. (n.d.). John B. Wetmore.",
        "source_2": "In the year 2030, the world was on the cusp of a medical revolution. Advances in technology and artificial intelligence had transformed the healthcare industry, and hospitals like the Royal Brisbane and Women's Hospital in Queensland, Australia, were at the forefront of this change. It was on April 2, 2030, that John B. Wetmore, a brilliant and ambitious researcher, joined the esteemed institution. Fresh from completing his Ph.D. in biomedical engineering, John was eager to apply his knowledge to real-world problems. The hospital's cutting-edge facilities and esteemed team of professionals provided the perfect environment for him to flourish. As John settled into his new role, he quickly became an integral part of the hospital's research team. His innovative approach to medical problem-solving and his ability to collaborate with colleagues from diverse backgrounds earned him the respect and admiration of his peers. The years that followed were a whirlwind of activity for John. He worked tirelessly to develop new treatments and therapies, often logging 12-hour days in the lab. His dedication paid off, as he made groundbreaking discoveries that improved patient outcomes and saved countless lives. As the years went by, John's reputation grew, both within the hospital and beyond. He became a sought-after speaker at international conferences, sharing his expertise with colleagues from around the world. His research papers were published in prestigious journals, and he was awarded numerous grants to fund his projects. But John's greatest achievement came in 2035, when he developed a revolutionary new treatment for a previously incurable disease. The breakthrough was hailed as a major milestone in medical history, and John was hailed as a hero. As the years drew to a close, John's thoughts turned to the next chapter of his career. He had accomplished everything he set out to do at the Royal Brisbane and Women's Hospital, and he felt the need to take on new challenges. On November 17, 2038, John bid farewell to his colleagues and friends, leaving behind a legacy that would continue to inspire and improve the lives of countless people. As he walked out of the hospital's doors for the last time, John couldn't help but feel a sense of pride and accomplishment. He had spent eight incredible years at the Royal Brisbane and Women's Hospital, and he knew that the experiences and knowledge he gained would stay with him forever."
    },
    "answer": "INSUFFICIENT_INFORMATION"
}